Parkwood LLC’s DICE Therapeutics DICE Stock Holding History
Bought
Maintained
Sold
Parkwood LLC's DICE Position: Q3 2023 in Review
Parkwood LLC sold out of DICE Therapeutics (DICE) in Q3 2023, closing a stake of 18,052 shares — an estimated $839K sold.
Parkwood LLC first reported a position in DICE in Q1 2022 and held it in 3 quarters. The position peaked at $839K in Q2 2023. 0 funds tracked by Wall St. Rank hold DICE as of Q3 2023.
- Parkwood LLC reported no remaining DICE Therapeutics position as of Q3 2023 after selling out during the quarter.
- Parkwood LLC sold 18,052 DICE Therapeutics shares in Q3 2023, an estimated $839K.
- Parkwood LLC first reported a position in DICE Therapeutics in Q1 2022 and held it in 3 quarters.
- Parkwood LLC's DICE Therapeutics position peaked at $839K in Q2 2023.
- 0 funds tracked by Wall St. Rank held DICE Therapeutics as of Q3 2023.
Based on Parkwood LLC's 13F filing for Q3 2023, filed 14 Nov 2023.